Catalyst

Slingshot members are tracking this event:

Merck (MRK) and Pfizer (PFE) Announce Phase 3 Results for Type 2 Diabetes Candidate Ertugliflozin

Source Link:
http://www.mercknewsroom.com/news-release/research-and-development-news/merck-and-pfizer-announce-investigational-ertugliflozin-m

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
PFE
100%
MRK
100%
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Sep 15, 2016
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Phase 3 Clinical Results, Vertis Sita2, Ertugliflozin
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.